Oral 12: Managing Soft Tissue Sarcoma is So Hard – A
Moderator:
Moderator:
Prof. Hirotaka Kawano (Teikyo University School of Medicine, Japan),
Prof. Ferdiansyah Mahyudin (Universitas Airlangga / Dr. Soetomo General Academic Hospital, Indonesia)
Special Lecture:
THE CHALLENGES OF SOFT TISSUE SARCOMA MANAGEMENT
Prof. Edward Wang(University of the Philippines Manila, Philippines)
Paper Number | Paper Title | Speaker/Moderator | Organization | Country |
---|---|---|---|---|
012-1 | STAGED SARCOMA RESECTION AND RECONSTRUCTION WITH NEGATIVE PRESSURE WOUND THERAPY IS ONCOLOGICALLY SAFE– A COMPARATIVE STUDY OF 137 SURGICALLY RESECTED SARCOMA’S WITH A MINIMUM 2-YEAR FOLLOW UP | Dr. Christopher Fang | Mohh Holdings Singapore | Singapore |
012-2 | EFFICACY OF LOW-DOSE .VS HIGH-DOSE INTRAVENOUS TRANEXAMIC ACID IN REDUCING BLOOD LOSS IN MAJOR MUSCULOSKELETAL ONCOLOGY SURGERY | Prof. Vivek Ajit Singh | University Malaya | Malaysia |
012-3 | PEDICLED GRACILIS MYOCUTANEOUS FLAP COVERAGE IN METASTATIC INGUINAL LYMPHADENOPATHY: A CASE SERIES | Dr. Lei Peng See | Hospital Queen Elizabeth | Malaysia |
012-4 | EVOLVING MANAGEMENT STRATEGIES FOR DESMOID-TYPE FIBROMATOSIS IN A SERIES OF 23 PATIENTS TREATED AT A SINGLE INSTITUTION | Dr. Chiao Yee Lim | Hospital Kuala Lumpur | Malaysia |
012-5 | WHAT TREATMENT MODALITY IS ASSOCIATED WITH BETTER PROGNOSIS IN PATIENTS WITH LOCALIZED/METASTATIC CLEAR CELL SARCOMA? A NATION-WIDE POPULATION-BASED STUDY | Dr. Tomohiro Fujiwara | Okayama University Hospital | Japan |
012-6 | NEOADJUVANT RADIOTHERAPY IS ASSOCIATED WITH FEWER ACUTE SKIN ADVERSE REACTIONS WITHOUT INCREASED RISK OF POSTOPERATIVE WOUND COMPLICATIONS IN HIGH-GRADE SOFT TISSUE SARCOMA OF THE EXTREMITY - A RETROSPECTIVE COMPARATIVE STUDY WITH A MEAN FOLLOW-UP OF 7 YEARS | Dr. Jacky Hiu Woo Lau | Prince of Wales Hospital | Hong Kong |
012-7 | DO WE NEED TO REEXCISE MACROSCOPICALLY COMPLETE UNPLANNED EXCISIONS OF SOFT TISSUE SARCOMAS OF THE EXTREMITIES? | Prof. Edward Wang | University of the Philippines Manila | Philippines |
012-8 | SURGICAL TREATMENT AND COMPLICATIONS OF DEEP-SEATED NODULAR PLEXIFORM NEUROFIBROMAS ASSOCIATED WITH NEUROFIBROMATOSIS TYPE 1 | Dr. Kunihiro Ikuta | Nagoya University Hospital | Japan |
012-9 | PAZOPANIB AS NEOADJUVANT CHEMOTHERAPY IN RESECTION OF DESMOID TUMORS | Dr. Eisuke Kobayashi | National Cancer Center Hospital | Japan |
012-10 | DIFFERENTIAL DIAGNOSIS OF LIPOMATOUS TUMORS ON 18F FLUORODEOXYGULCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY | Dr. Hiromichi Oshiro | University Of The Ryukyus | Japan |
012-11 | DEVELOPMENT AND VALIDATION OF A RISK SCORING SYSTEM TO PREDICT SURGICAL-SITE INFECTION AFTER SOFT-TISSUE SARCOMA RESECTION | Dr. Shinji Miwa | Kanazawa University | Japan |
012-12 | CLINICAL SIGNIFICANCE OF DNA METHYLATION STATUS IN SOFT TISSUE SARCOMAS | Dr. Min Wook Joo | The Catholic University Of Korea | South Korea |
Q&A / Panel Discussion |